| Texas Fertility Center | 77.2 | 3 | 1 |
| Prelude Fertility | 77.2 | 3 | 1 |
| Pacific Fertility Center Los Angeles (PFCLA) | 77.2 | 3 | 1 |
| Colorado Center for Reproductive Medicine | 64.8 | 2 | 1 |
| Sher Fertility | 64.8 | 2 | 1 |
| National Institute for Occupational Safety and Health | 60.0 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 60.0 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 60.0 | 3 | 0 |
| Pacific Fertility Center | 60.0 | 3 | 0 |
| Office of Readiness and Response | 60.0 | 3 | 0 |
| Epi Info | 47.5 | 2 | 0 |
| Mercy Health | 47.5 | 2 | 0 |
| Preventing Chronic Disease | 47.5 | 2 | 0 |
| National Survey of Family Growth | 47.5 | 2 | 0 |
| National Vital Statistics System | 47.5 | 2 | 0 |
| NIOSH Power Tools Database | 47.5 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 47.5 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 47.5 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 47.5 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 47.5 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 47.5 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 47.5 | 2 | 0 |
| NCHS data brief | 47.5 | 2 | 0 |
| MMWR supplements | 47.5 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 47.5 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 47.5 | 2 | 0 |
| Fertility Center of San Antonio | 47.5 | 2 | 0 |
| San Diego Fertility Center | 47.5 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 47.5 | 2 | 0 |
| Fertility Center of Las Vegas | 47.5 | 2 | 0 |
| Shady Grove Fertility Center | 47.5 | 2 | 0 |
| Cooper Health System | 47.5 | 2 | 0 |
| Fertility Centers of Illinois | 47.5 | 2 | 0 |
| New Hope Fertility Center | 47.5 | 2 | 0 |
| Healthcare Infection Control Practices Advisory Committee | 47.5 | 2 | 0 |
| Progyny, Inc. | 47.5 | 2 | 0 |
| American Society for Reproductive Medicine | 47.2 | 1 | 1 |
| Seattle Reproductive Medicine | 47.2 | 1 | 1 |
| Reproductive Medicine Associates of New York | 47.2 | 1 | 1 |
| Reproductive Medicine Associates of New Jersey | 47.2 | 1 | 1 |
| Reproductive Medicine Institute | 47.2 | 1 | 1 |
| Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs | 40.0 | 0 | 4 |
| assisted reproductive technology | 34.5 | 0 | 3 |
| egg donation | 34.5 | 0 | 3 |
| fertility clinic | 34.5 | 0 | 3 |
| third-party reproduction | 34.5 | 0 | 3 |
| Fertility and Sterility | 34.5 | 0 | 3 |
| Determining parental origin of embryo aneuploidy: analysis of genetic error observed in 305 embryos derived from anonymous donor oocyte IVF cycles | 34.5 | 0 | 3 |
| Differences in pregnancy outcomes in donor egg frozen embryo transfer (FET) cycles following preimplantation genetic screening (PGS): a single center retrospective study | 34.5 | 0 | 3 |
| Controversies in assisted reproduction: oocyte donation. Protocols for egg donation | 34.5 | 0 | 3 |
| Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction? | 34.5 | 0 | 3 |
| Assisted Hatching of the Zona Pellucida Prior to Embryo Transfer in Fresh Donor Egg IVF Cycles | 34.5 | 0 | 3 |
| Pre-implantation genetic screening (PGS) in donor oocyte IVF cycles: a practice survey | 34.5 | 0 | 3 |
| United States Centers for Disease Control and Prevention | 30.0 | 1 | 0 |
| Creighton University | 30.0 | 1 | 0 |
| Human Fertilisation and Embryology Authority | 30.0 | 1 | 0 |
| Morbidity and Mortality Weekly Report | 30.0 | 1 | 0 |
| Brigham and Women's Hospital | 30.0 | 1 | 0 |
| National Center for Health Statistics | 30.0 | 1 | 0 |
| Weill Cornell Medicine | 30.0 | 1 | 0 |
| Advisory Committee on Immunization Practices | 30.0 | 1 | 0 |
| Anne Schuchat | 30.0 | 1 | 0 |
| Conceive | 30.0 | 1 | 0 |
| Cooper University Hospital | 30.0 | 1 | 0 |
| Emerging Infectious Diseases | 30.0 | 1 | 0 |
| Epi Map | 30.0 | 1 | 0 |
| Epidemic Intelligence Service | 30.0 | 1 | 0 |
| Fire Fighter Fatality Investigation and Prevention Program | 30.0 | 1 | 0 |
| Genetics and IVF Institute | 30.0 | 1 | 0 |
| Health Hazard Evaluation | 30.0 | 1 | 0 |
| Highland Hospital | 30.0 | 1 | 0 |
| NYU Langone Health | 30.0 | 1 | 0 |
| National Center for Injury Prevention and Control | 30.0 | 1 | 0 |
| National Diabetes Education Program | 30.0 | 1 | 0 |
| National Health Interview Survey | 30.0 | 1 | 0 |
| Nicholas H Noyes Memorial Hospital | 30.0 | 1 | 0 |
| Public Health Information Network | 30.0 | 1 | 0 |
| Sanford Health | 30.0 | 1 | 0 |
| Sanford USD Medical Center | 30.0 | 1 | 0 |
| St. John's Parish | 30.0 | 1 | 0 |
| St. Rita's Medical Center | 30.0 | 1 | 0 |
| St. Vincent Mercy Children's Hospital | 30.0 | 1 | 0 |
| Strong Memorial Hospital | 30.0 | 1 | 0 |
| UCSF Medical Center | 30.0 | 1 | 0 |
| University of Rochester Medical Center | 30.0 | 1 | 0 |
| VERB | 30.0 | 1 | 0 |
| Vaccines for Children Program | 30.0 | 1 | 0 |
| NIOSH World Trade Center Health Program | 30.0 | 1 | 0 |
| Theodore H. Schwartz | 30.0 | 1 | 0 |
| Journal of Religion and Society | 30.0 | 1 | 0 |
| National Death Index | 30.0 | 1 | 0 |
| National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention | 30.0 | 1 | 0 |
| National Center for Immunization and Respiratory Diseases | 30.0 | 1 | 0 |
| NIOSH pocket guide to chemical hazards (superseded) | 30.0 | 1 | 0 |
| National Violent Death Reporting System | 30.0 | 1 | 0 |
| Sonja A. Rasmussen | 30.0 | 1 | 0 |
| Monthly vital statistics report : provisional statistics from the National Center for Health Statistics | 30.0 | 1 | 0 |
| Advance data | 30.0 | 1 | 0 |
| Vital and health statistics. Series 10, Data from the National Health Survey | 30.0 | 1 | 0 |
| Vital and health statistics. Series 11, Data from the national health survey | 30.0 | 1 | 0 |
| Vital and health statistics. Series 21, Data from the National Vital Statistics System | 30.0 | 1 | 0 |
| Vital and health statistics. Series 23, Data from the National Survey of Family Growth | 30.0 | 1 | 0 |
| Vital and health statistics. Series 20, Data from the National Vital Statistics System | 30.0 | 1 | 0 |
| National health statistics reports | 30.0 | 1 | 0 |
| Office of Public Health Genomics | 30.0 | 1 | 0 |
| Hartmut Land | 30.0 | 1 | 0 |
| Office of Public Health Preparedness and Response | 30.0 | 1 | 0 |
| Office for State, Tribal, Local and Territorial Support | 30.0 | 1 | 0 |
| Center for Global Health | 30.0 | 1 | 0 |
| San Juan Quarantine Station | 30.0 | 1 | 0 |
| Barcelona IVI Clinic | 30.0 | 1 | 0 |
| IVI Madrid Clinic | 30.0 | 1 | 0 |
| IVI Sevilla Clinic | 30.0 | 1 | 0 |
| IVI Valencia Clinic | 30.0 | 1 | 0 |
| Boston IVF | 30.0 | 1 | 0 |
| Igenomix | 30.0 | 1 | 0 |
| Fairfield Hospital | 30.0 | 1 | 0 |
| Sanford Heart Hospital | 30.0 | 1 | 0 |
| National Center for Environmental Health | 30.0 | 1 | 0 |
| Center for Human Reproduction | 30.0 | 1 | 0 |
| National Center for Infectious Diseases | 30.0 | 1 | 0 |
| Valencian Infertility Institute | 30.0 | 1 | 0 |
| Sanford Children's Specialty Clinic | 30.0 | 1 | 0 |
| Golisano Children's Hospital | 30.0 | 1 | 0 |
| St. Elizabeth Youngstown Hospital | 30.0 | 1 | 0 |
| National Center on Birth Defects and Developmental Disabilities | 30.0 | 1 | 0 |
| Division of Regulatory Science and Compliance | 30.0 | 1 | 0 |
| Office of Infectious Diseases | 30.0 | 1 | 0 |
| Center for Surveillance, Epidemiology, and Laboratory Services | 30.0 | 1 | 0 |
| Office of Minority Health and Health Equity | 30.0 | 1 | 0 |
| preimplantation genetic diagnosis | 27.3 | 0 | 2 |
| Journal of Assisted Reproduction and Genetics | 27.3 | 0 | 2 |
| Reproductive Medicine and Biology | 27.3 | 0 | 2 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 27.3 | 0 | 2 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 27.3 | 0 | 2 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 27.3 | 0 | 2 |
| Pregnancy after oocyte donation in 45, X Turner syndrome women, complicated by gestational diabetes and polyhydramnios. Case report and mini-review of literature | 27.3 | 0 | 2 |
| Predictors of participant retention in infertility treatment trials | 27.3 | 0 | 2 |
| A two- versus three-embryo transfer: the oocyte donation model | 27.3 | 0 | 2 |
| Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique | 27.3 | 0 | 2 |
| Initial experience with a donor egg bank | 27.3 | 0 | 2 |
| Fertility clinic, egg donation agency, and sperm bank policies | 27.3 | 0 | 2 |
| Serum progesterone concentration on day of embryo transfer in donor oocyte cycles | 27.3 | 0 | 2 |
| Treatment decision making in anonymous donor egg in-vitro fertilisation: a qualitative study of childless women and women with genetically related children. | 27.3 | 0 | 2 |
| Effect of male hepatitis B virus infection on outcomes of in vitro fertilization and embryo transfer treatment: insights from couples undergoing oocyte donation | 27.3 | 0 | 2 |
| Oocyte donation in infertility treatment--a review | 27.3 | 0 | 2 |
| Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo? | 27.3 | 0 | 2 |
| Monozygotic twins with discordant karyotypes following preimplantation genetic screening and single embryo transfer: case report | 27.3 | 0 | 2 |
| Primary ovarian pregnancy after donor embryo transfer: early diagnosis and laparoscopic treatment. | 27.3 | 0 | 2 |
| Successful in vitro fertilization with anonymous donor oocytes in a patient with recurrent massive hemoperitoneum following spontaneous and induced ovulation | 27.3 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion | 27.3 | 0 | 2 |
| Establishment of comparative performance criteria for IVF centers: correlation of live birth rates in autologous and donor oocyte IVF cycles | 27.3 | 0 | 2 |
| Evaluation of cystic fibrosis carrier screening programs according to genetic screening criteria | 27.3 | 0 | 2 |
| A healthy delivery of twins by assisted reproduction followed by preimplantation genetic screening in a woman with X-linked dominant incontinentia pigmenti | 27.3 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 27.3 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 27.3 | 0 | 2 |
| Donor egg IVF model to assess ecological implications for ART success | 27.3 | 0 | 2 |
| Developmental stage on day-5 and fragmentation rate on day-3 can influence the implantation potential of top-quality blastocysts in IVF cycles with single embryo transfer | 27.3 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality | 27.3 | 0 | 2 |
| Preimplantation genetic screening of blastocysts by multiplex qPCR followed by fresh embryo transfer: validation and verification | 27.3 | 0 | 2 |
| The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal? | 27.3 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| The role of uterine straightening by passive bladder distension before embryo transfer in IVF cycles | 27.3 | 0 | 2 |
| Recruiting egg donors online: an analysis of in vitro fertilization clinic and agency websites' adherence to American Society for Reproductive Medicine guidelines | 27.3 | 0 | 2 |
| Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons | 27.3 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 27.3 | 0 | 2 |
| Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. | 27.3 | 0 | 2 |
| Preimplantation genetic testing: a Practice Committee opinion | 27.3 | 0 | 2 |
| Effect of powdered gloves, worn at the time of embryo transfer, on the pregnancy outcome of IVF cycles | 27.3 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 27.3 | 0 | 2 |
| Repetitive oocyte donation | 27.3 | 0 | 2 |
| Cloning endangered felids using heterospecific donor oocytes and interspecies embryo transfer | 27.3 | 0 | 2 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 27.3 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 27.3 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 27.3 | 0 | 2 |
| Multiple births from fertility treatment in the UK: A Consensus statement | 27.3 | 0 | 2 |
| Elective single-embryo transfer | 27.3 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion | 27.3 | 0 | 2 |
| The wobbly evidence base of reproductive medicine | 27.3 | 0 | 2 |
| Misconduct in third-party assisted reproduction: a committee opinion | 27.3 | 0 | 2 |
| Methods employed to overcome difficult embryo transfer during assisted reproduction treatment | 27.3 | 0 | 2 |
| The importance of the length of uterine cavity, the position of the tip of the inner catheter and the distance between the fundal endometrial surface and the air bubbles as determinants of the pregnancy rate in IVF cycles | 27.3 | 0 | 2 |
| Subclinical hypothyroidism in the infertile female population: a guideline | 27.3 | 0 | 2 |
| Comprehensive chromosome screening improves embryo selection: a meta-analysis | 27.3 | 0 | 2 |
| Impact of preimplantation genetic screening on donor oocyte-recipient cycles in the United States | 27.3 | 0 | 2 |
| The effect of peri-implantation administration of uterine relaxing agents in assisted reproduction treatment cycles: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Delayed intracytoplasmic sperm injection (ICSI) with trophectoderm biopsy and preimplantation genetic screening (PGS) show increased aneuploidy rates but can lead to live births with single thawed euploid embryo transfer (STEET). | 27.3 | 0 | 2 |
| Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 27.3 | 0 | 2 |
| A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health | 27.3 | 0 | 2 |
| Performing the embryo transfer: a guideline | 27.3 | 0 | 2 |
| Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report | 27.3 | 0 | 2 |
| Determining the need for rescue intracytoplasmic sperm injection in partial fertilisation failure during a conventional IVF cycle | 27.3 | 0 | 2 |
| Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer | 27.3 | 0 | 2 |
| Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction? | 27.3 | 0 | 2 |
| Obstetric and perinatal complications in an oocyte donation programme. Is it time to limit the number of embryos to transfer? | 27.3 | 0 | 2 |
| Oocyte donation--implications for fertility treatment in the nineties. | 27.3 | 0 | 2 |
| Strategy for the prevention of transfusion-transmitted hepatitis--current state of blood donor screening test | 27.3 | 0 | 2 |
| Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012 | 27.3 | 0 | 2 |
| Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion | 27.3 | 0 | 2 |
| Optimal euploid embryo transfer strategy, fresh versus frozen, after preimplantation genetic screening with next generation sequencing: a randomized controlled trial. | 27.3 | 0 | 2 |
| The yield of universal antibody to hepatitis B core antigen donor screening in theNetherlands, a hepatitis B virus low‐endemic country | 27.3 | 0 | 2 |
| Prognosis of oocyte donation cycles: a prospective comparison of the in vitro fertilization-embryo transfer cycles of recipients who used shared oocytes versus those who used altruistic donors | 27.3 | 0 | 2 |
| Comparison of pregnancy rates following in vitro fertilization-embryo transfer between the donors and the recipients in a donor oocyte program | 27.3 | 0 | 2 |
| Egg sharing and egg donation: attitudes of British egg donors and recipients | 27.3 | 0 | 2 |
| IVF Treatment and Single Embryo Transfer | 27.3 | 0 | 2 |
| Successful pregnancy with frozen embryo transfer into a gestational carrier from eggs obtained from a woman in premature menopause | 27.3 | 0 | 2 |
| Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction | 27.3 | 0 | 2 |
| Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit | 27.3 | 0 | 2 |
| Repetitive oocyte donation: a committee opinion | 27.3 | 0 | 2 |
| Fresh embryo transfer is more effective than frozen for donor oocyte recipients but not for donors | 27.3 | 0 | 2 |
| Life after unsuccessful IVF treatment in an assisted reproduction unit: a qualitative analysis of gains through loss among Chinese persons in Hong Kong. | 27.3 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 27.3 | 0 | 2 |
| Successful pregnancy using known donor oocytes fertilized in vitro by spermatozoa obtained by electro-ejaculation from a quadriplegic husband | 27.3 | 0 | 2 |
| The effect of smoking on infertility treatment in women undergoing assisted reproduction cycles | 27.3 | 0 | 2 |
| The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment | 27.3 | 0 | 2 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 27.3 | 0 | 2 |
| Blastocyst euploidy and implantation rates in a young (<35 years) and old (≥35 years) presumed fertile and infertile patient population | 27.3 | 0 | 2 |
| Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine | 27.3 | 0 | 2 |
| Risk-sharing or refund programs in assisted reproduction: a committee opinion | 27.3 | 0 | 2 |
| Reproductive medicine and the law: egg donation in Germany, Spain and other European countries | 27.3 | 0 | 2 |
| Blastocentesis: a source of DNA for preimplantation genetic testing. Results from a pilot study | 27.3 | 0 | 2 |
| Assisted reproduction professionals' awareness and attitudes towards their own IVF cycles | 27.3 | 0 | 2 |
| Outcomes of donor oocyte cycles in assisted reproduction | 27.3 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 27.3 | 0 | 2 |
| Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates | 27.3 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 27.3 | 0 | 2 |
| Repeat trials of oocyte donation to women with previous donor oocyte success | 27.3 | 0 | 2 |
| Successful outcome after preimplantation genetic screening and very delayed embryo transfer | 27.3 | 0 | 2 |
| Public policy aspects of assisted reproduction. Vth World Congress, IVF and embryo transfer | 27.3 | 0 | 2 |
| Posthumous assisted reproduction: a survey of attitudes of couples seeking fertility treatment and the degree of agreement between intimate partners | 27.3 | 0 | 2 |
| Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria. | 27.3 | 0 | 2 |
| Factors associated with dizygotic twinning after IVF treatment with double embryo transfer | 27.3 | 0 | 2 |
| Endometrial biopsy during hormone replacement cycle in donor oocyte recipients before in vitro fertilization-embryo transfer | 27.3 | 0 | 2 |
| Alterations in the sperm histone-retained epigenome are associated with unexplained male factor infertility and poor blastocyst development in donor oocyte IVF cycles | 27.3 | 0 | 2 |
| The Importance of the Periconception Period: Immediate Effects in Cattle Breeding and in Assisted Reproduction Such as Artificial Insemination and Embryo Transfer | 27.3 | 0 | 2 |
| Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion | 27.3 | 0 | 2 |
| The impact of the new Turkish regulation, imposing single embryo transfer after assisted reproduction technology, on neonatal intensive care unit utilization: a single center experience. | 27.3 | 0 | 2 |
| High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer | 27.3 | 0 | 2 |
| Donor Motivations, Associated Risks and Ethical Considerations of Oocyte Donation | 27.3 | 0 | 2 |
| Consideration of the gestational carrier: a committee opinion | 27.3 | 0 | 2 |
| Endometrial thickness as a predictor of the reproductive outcomes in fresh and frozen embryo transfer cycles: A retrospective cohort study of 1512 IVF cycles with morphologically good-quality blastocyst | 27.3 | 0 | 2 |
| Corrigendum: Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study | 27.3 | 0 | 2 |
| Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study | 27.3 | 0 | 2 |
| Re: Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis: Significance of advising women prior to fertility treatment | 27.3 | 0 | 2 |
| Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort | 27.3 | 0 | 2 |
| Cryopreserved embryo transfer: adjacent or non-adjacent to failed fresh long GnRH-agonist protocol IVF cycle | 27.3 | 0 | 2 |
| American Society for Reproductive Medicine Updates Consent Forms for Egg Donation | 27.3 | 0 | 2 |
| Do donor oocyte cycles comply with ASRM/SART embryo transfer guidelines? An analysis of 13,393 donor cycles from the SART registry | 27.3 | 0 | 2 |
| Endometrial preparation: effect of estrogen dose and administration route on reproductive outcomes in oocyte donation cycles with fresh embryo transfer | 27.3 | 0 | 2 |
| Preimplantation genetic testing: polar bodies, blastomeres, trophectoderm cells, or blastocoelic fluid? | 27.3 | 0 | 2 |
| Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure | 27.3 | 0 | 2 |
| Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology | 27.3 | 0 | 2 |
| The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction technology | 27.3 | 0 | 2 |
| Elective single-embryo transfer in oocyte donation programmes: Should it be the rule? | 27.3 | 0 | 2 |
| Comparison of pregnancy outcome following frozen embryo transfer (ET) in a gestational carrier program according to source of the oocytes | 27.3 | 0 | 2 |
| Transvaginal versus transabdominal ultrasound guidance for embryo transfer in donor oocyte recipients: a randomized clinical trial | 27.3 | 0 | 2 |
| Blastocyst embryo transfer is the primary determinant for improved outcomes in oocyte donation cycles | 27.3 | 0 | 2 |
| Five years of single embryo transfer with anonymous and non-anonymous oocyte donation | 27.3 | 0 | 2 |
| Elective single embryo transfer yields good delivery rates in oocyte donation. | 27.3 | 0 | 2 |
| Minimal genetic screening for gamete donors | 27.3 | 0 | 2 |
| Guidelines for oocyte donation | 27.3 | 0 | 2 |
| Assisted reproduction technique outcomes for fresh versus deferred cryopreserved day-2 embryo transfer: a retrospective matched cohort study | 27.3 | 0 | 2 |
| Ultrasound guided embryo transfer significantly improves pregnancy rates in women undergoing oocyte donation | 27.3 | 0 | 2 |
| Comparison of buserelin and nafarelin in IVF cycles and in subsequent frozen-thawed embryo transfer cycles | 27.3 | 0 | 2 |
| The window for embryo transfer in oocyte donation cycles depends on the duration of progesterone therapy | 27.3 | 0 | 2 |
| Ethical issues of egg donation | 27.3 | 0 | 2 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 27.3 | 0 | 2 |
| Spontaneous resolution of ectopic pregnancy in a surrogate after oocyte donation and frozen embryo transfer | 27.3 | 0 | 2 |
| Twin pregnancy following embryo transfer on day 7 of the luteal phase in an oocyte donation programme | 27.3 | 0 | 2 |
| Ethical quandaries around expanded carrier screening in third-party reproduction. | 27.3 | 0 | 2 |
| Success of donor oocyte in in vitro fertilization-embryo transfer in recipients with and without premature ovarian failure | 27.3 | 0 | 2 |
| Evaluation of the mechanism for higher pregnancy rates in donor oocyte recipients by comparison of fresh with frozen embryo transfer pregnancy rates in a shared oocyte programme | 27.3 | 0 | 2 |
| Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation | 27.3 | 0 | 2 |
| The effect of endometrial thickness and echo pattern on in vitro fertilization outcome in donor oocyte-embryo transfer cycle. | 27.3 | 0 | 2 |
| Birthweight of singletons after assisted reproduction is higher after single- than after double-embryo transfer | 27.3 | 0 | 2 |
| Expanded carrier screening: what the reproductive endocrinologist needs to know | 27.3 | 0 | 2 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 27.3 | 0 | 2 |
| Comparison of embryo transfer strategies and assisted reproduction outcome in Slovenian and cross-border patients | 27.3 | 0 | 2 |
| CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer | 27.3 | 0 | 2 |
| Bioethical dilemmas of assisted reproduction in the opinions of Polish women in infertility treatment: a research report | 27.3 | 0 | 2 |
| Costs of medically assisted reproduction treatment at specialized fertility clinics in the Danish public health care system: results from a 5-year follow-up cohort study | 27.3 | 0 | 2 |
| International egg-sharing to provide donor oocytes for clinical assisted reproduction and derivation of nuclear transfer stem cells | 27.3 | 0 | 2 |
| Egg-sharing across international borders. This may ease the shortage of donor oocytes in more economically developed countries while making fertility treatment affordable to childless couples from poorer countries | 27.3 | 0 | 2 |
| Egg-sharing in return for subsidized fertility treatment--an ethically justifiable and practical solution to overcome the shortage of donor oocytes for therapeutic cloning | 27.3 | 0 | 2 |
| The 2004 Italian legislation regulating assisted reproduction technology: a multicentre survey on the results of IVF cycles | 27.3 | 0 | 2 |
| Use of fetal oocytes in assisted reproduction | 27.3 | 0 | 2 |
| Oocyte donation to postmenopausal women | 27.3 | 0 | 2 |
| Guidelines for oocyte donation | 27.3 | 0 | 2 |
| Pregnancy following oocyte donation and tubal embryo transfer in patients with premature ovarian failure: report of two cases | 27.3 | 0 | 2 |
| Premarital genetic screening for beta thalassemia carrier status of indexed families using HbA2 electrophoresis | 27.3 | 0 | 2 |
| Multinucleation of a sibling blastomere on day 2 suggests unsuitability for embryo transfer in IVF–preimplantation genetic screening cycles | 27.3 | 0 | 2 |
| Expectations for success in fertility treatment involving assisted reproduction | 27.3 | 0 | 2 |
| Reproductive medicine in transition: new developments in embryo transfer | 27.3 | 0 | 2 |
| Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer | 27.3 | 0 | 2 |
| AIDA for reproductive medicine and the fertility clinic | 27.3 | 0 | 2 |
| Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? | 27.3 | 0 | 2 |
| Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles | 27.3 | 0 | 2 |
| Comparison of the effect of immediate versus delayed transfer following a stimulated IVF cycle on the ongoing pregnancy rate of frozen-thawed embryo transfer cycles: a study protocol for a randomised controlled trial. | 27.3 | 0 | 2 |
| Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal | 27.3 | 0 | 2 |
| In-vitro fertilization (IVF), embryo transfer (ET) and assisted reproduction in the State of Israel | 27.3 | 0 | 2 |
| Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer | 27.3 | 0 | 2 |
| Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence? | 27.3 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage | 27.3 | 0 | 2 |
| How much does the uterus matter? Perinatal outcomes are improved when donor oocyte embryos are transferred to gestational carriers compared to intended parent recipients | 27.3 | 0 | 2 |
| Consideration of the gestational carrier: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Misconduct in third-party assisted reproduction: an Ethics Committee opinion | 27.3 | 0 | 2 |
| THE OPTIMAL INTERVAL OF TIME FROM OPERATIVE HYSTEROSCOPY TO EMBRYO TRANSFER IN AN IVF CYCLE | 27.3 | 0 | 2 |
| Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinion | 27.3 | 0 | 2 |
| Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Gender reassignment and assisted reproduction: An ethical analysis. Bristol Centre for Reproductive Medicine Ethics Advisory Committee | 27.3 | 0 | 2 |
| Shared-risk or refund programs in assisted reproduction. The Ethics Committee of the American Society for Reproductive Medicine | 27.3 | 0 | 2 |
| How much does the uterus matter? perinatal outcomes are improved when donor oocyte embryos are transferred to gestational carriers compared to intended parent recipients: an analysis of the 2014 SART data | 27.3 | 0 | 2 |
| The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow-up study**Presented in part at the 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Wa | 27.3 | 0 | 2 |
| Single Human Embryo Transfer in Assisted Reproduction Programs | 27.3 | 0 | 2 |
| Clinical Cohort Study on the Endocrinology and Vaginal Microbiome of the Luteal Phase in Assisted Reproduction | 27.3 | 0 | 2 |
| Ultrasound Study by Texturization as a Predictor of Pregnancy in Oocyte Donation Programs | 27.3 | 0 | 2 |
| The Effect of Embryo Culture Under Low Oxygen Tension on Pregnancy Rates | 27.3 | 0 | 2 |
| Single Embryo Transfer vs. Double Embryo Transfer in an Oocyte Donation Programme | 27.3 | 0 | 2 |
| Methylprednisolone Addition in IVF Treatment of Infertile Couples | 27.3 | 0 | 2 |
| Risk of pre-eclampsia after fresh or frozen embryo transfer in patients undergoing oocyte donation | 27.3 | 0 | 2 |
| Pre-Implantation Genetic Screening in Women Under the Age of 36 Years With Single Embryo Transfer | 27.3 | 0 | 2 |
| What advice should we give our patients to preserve their fertility and avoid needing oocyte donation in the future? - A Social Fertility Preservation program | 27.3 | 0 | 2 |
| Safety data for the use of nasal human menopausal gonadotropins: a potential novel approach for fertility treatment | 27.3 | 0 | 2 |
| Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics | 27.3 | 0 | 2 |
| Live birth and multiple birth rates in US in vitro fertilization treatment using donor oocytes: a comparison of single-embryo transfer and double-embryo transfer | 27.3 | 0 | 2 |
| Single Embryo TrAnsfeR of Euploid Embryo | 27.3 | 0 | 2 |
| A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment | 27.3 | 0 | 2 |
| Bed Rest or no Bed Rest? | 27.3 | 0 | 2 |
| EmbryoGlue as an Embryo Transfer Medium | 27.3 | 0 | 2 |
| The Accuracy of Endometrial Ultrasound to Predict Implantation | 27.3 | 0 | 2 |
| Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates | 27.3 | 0 | 2 |
| The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos) | 27.3 | 0 | 2 |
| Vitamin D Influence on Oocyte Donation | 27.3 | 0 | 2 |
| Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles | 27.3 | 0 | 2 |
| Oocyte Recipient's Decision in the Number of Embryos to be Transferred | 27.3 | 0 | 2 |
| Immediate Versus Delayed FET Following a Stimulated IVF Cycle | 27.3 | 0 | 2 |
| The Effect of Acupuncture on Pregnancy Rates in Women Undergoing in Vitro Fertilization With Preimplantation Genetic Screening | 27.3 | 0 | 2 |
| Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment | 27.3 | 0 | 2 |
| Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound | 27.3 | 0 | 2 |
| Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer | 27.3 | 0 | 2 |
| In vitro fertilization and other assisted reproduction. Vth World Congress on In Vitro Fertilization and Embryo Transfer. Norfolk, Virginia, April 5-10, 1987. Proceedings | 27.3 | 0 | 2 |
| Methodology of human embryo transfer following assisted reproduction | 27.3 | 0 | 2 |
| Reproductive medicine and assisted reproduction--present status and perspectives in the Czech Republic | 27.3 | 0 | 2 |
| High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles | 27.3 | 0 | 2 |
| A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice opinion. American Society for Reproductive Immunology Antiphospholipid | 27.3 | 0 | 2 |
| The influence of infertility treatment and assisted reproduction techniques on multiple pregnancy rates | 27.3 | 0 | 2 |
| Hormonal therapy for the synchronization between donor and recipient in an oocyte donation and surrogacy fertilization in vitro-embryo transfer program | 27.3 | 0 | 2 |
| Embryo transfer: a critical step in assisted reproduction | 27.3 | 0 | 2 |
| The Impact of Lifestyle on Sperm Telomere Length and Telomerase Activity in Men Undergoing IVF Treatments | 27.3 | 0 | 2 |
| Repetitive oocyte donation | 27.3 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 27.3 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 27.3 | 0 | 2 |
| Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 27.3 | 0 | 2 |
| [Towards a single embryo transfer: predictive value of uterine and embryological parameters in assisted reproduction outcome] | 27.3 | 0 | 2 |
| Elective single embryo transfer in assisted reproduction | 27.3 | 0 | 2 |
| Health of children born after the infertility treatment with Assisted Reproduction Technology | 27.3 | 0 | 2 |
| Removal of cervical mucus prior to embryo transfer improves pregnancy rates in women undergoing assisted reproduction | 27.3 | 0 | 2 |
| Appendix A: minimal genetic screening for gamete donors | 27.3 | 0 | 2 |
| Blastocyst production and transfer in clinical assisted reproduction | 27.3 | 0 | 2 |
| Repetitive oocyte donation | 27.3 | 0 | 2 |
| Shared-risk or refund programs in assisted reproduction | 27.3 | 0 | 2 |
| Embryo splitting for infertility treatment | 27.3 | 0 | 2 |
| Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples | 27.3 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 27.3 | 0 | 2 |
| Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment? | 27.3 | 0 | 2 |
| In vitro fertilization laboratory. Clinical features of assisted reproduction techniques. Male infertility treatment in a reproduction medicine centre | 27.3 | 0 | 2 |
| Preimplantation genetic screening will play a dominant role in selecting embryos for single embryo transfer | 27.3 | 0 | 2 |
| Elective single embryo transfer versus double embryo transfer in assisted reproduction | 27.3 | 0 | 2 |
| Single embryo transfer in IVF treatment | 27.3 | 0 | 2 |
| Preimplantation genetic testing: a Practice Committee opinion | 27.3 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 27.3 | 0 | 2 |
| Effect of the new legislation and single-embryo transfer policy in Turkey on assisted reproduction outcomes: preliminary results | 27.3 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile: a committee opinion | 27.3 | 0 | 2 |
| Results after assisted reproduction at a public fertility clinic | 27.3 | 0 | 2 |
| Effect of different embryo transfer strategies on the outcome of assisted reproduction | 27.3 | 0 | 2 |
| Uterine contractile activity at Embryo Transfer – as a new pharmacotherapeutic target in assisted reproduction | 27.3 | 0 | 2 |
| Genetic screening in the American Society for Reproductive Medicine's new guidelines on diagnostic evaluation of the infertile male | 27.3 | 0 | 2 |
| Psychosocial factors in reproductive medicine | 27.3 | 0 | 2 |
| Progress of improving blood donor screening by nucleic acid technology | 27.3 | 0 | 2 |
| Successful pregnancy following assisted reproduction and transmyometrial embryo transfer in a patient with anatomical distortion of the cervical canal | 27.3 | 0 | 2 |
| The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion | 27.3 | 0 | 2 |
| Next generation sequencing for preimplantation genetic screening improves pregnancy outcomes compared with array comparative genomic hybridization in single thawed euploid embryo transfer cycles | 27.3 | 0 | 2 |
| Split happens: a case of consecutive monozygotic twin pregnancies following elective single-embryo transfer in a 40-year old woman using donor oocytes | 27.3 | 0 | 2 |
| ASRM standard embryo transfer protocol template: a committee opinion | 27.3 | 0 | 2 |
| Compassionate transfer: patient requests for embryo transfer for nonreproductive purposes | 27.3 | 0 | 2 |
| The effect of fresh IVF cycle characteristics on frozen embryo transfer (FET) outcomes | 27.3 | 0 | 2 |
| Preimplantation genetic testing in assisted reproduction technology | 27.3 | 0 | 2 |
| Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion | 27.3 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial | 27.3 | 0 | 2 |
| Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic | 27.3 | 0 | 2 |
| Curative effect of assisted reproduction technology by Traditional Chinese Medicine multi-channel interventional therapy on 95 cases of in vitro fertilization and embryo transfer failure | 27.3 | 0 | 2 |
| Androgenicity and fertility treatment in women with unexplained infertility | 27.3 | 0 | 2 |
| A Comparison of Pregnancy Outcomes in Patients Undergoing Donor Egg Single Embryo Transfers With and Without Preimplantation Genetic Testing | 27.3 | 0 | 2 |
| Preimplantation genetic screening should be used in all in vitro fertilisation cycles in women over the age of 35 years: AGAINST: Pre-implantation genetic screening should not be used in all IVF cycles in women over the age of 35 years | 27.3 | 0 | 2 |
| Second-generation preimplantation genetic testing for aneuploidy in assisted reproduction: a SWOT analysis | 27.3 | 0 | 2 |
| Increased incidence of obstetric and perinatal complications in pregnancies achieved using donor oocytes and single embryo transfer in young and healthy women. A prospective hospital-based matched cohort study | 27.3 | 0 | 2 |
| Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment | 27.3 | 0 | 2 |
| Comparison of perinatal outcomes following frozen embryo transfer cycles using autologous versus donor oocytes in women 40 to 43 years old: analysis of SART CORS data | 27.3 | 0 | 2 |
| Influence of surgical evacuation on pregnancy outcomes of subsequent embryo transfer cycle following miscarriage in an initial IVF cycle: a retrospective cohort study | 27.3 | 0 | 2 |
| Acceptance of Donor Eggs, Donor Sperms, or Donor Embryos in Indian Infertile Couples | 27.3 | 0 | 2 |
| Reply: The transnational fresh oocyte donation. Should it be the first choice when implementing an egg donation program in countries with low availability of donors? | 27.3 | 0 | 2 |
| The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic | 27.3 | 0 | 2 |
| [Medically Assisted Reproduction in Natural Cycle: Outcome Evaluation of a Reproductive Medicine Department] | 27.3 | 0 | 2 |
| Corticosteroids Prior to Embryo Transfer in Assisted Reproduction in Women with Crohn's Disease and Ulcerative Colitis - A Nationwide Cohort Study | 27.3 | 0 | 2 |
| Endometriosis and cumulative live birth rate after fresh and frozen IVF cycles with single embryo transfer in young women: no impact beyond reduced ovarian sensitivity-a case control study | 27.3 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer | 27.3 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer-Reply | 27.3 | 0 | 2 |
| Transfer of embryos with positive results following preimplantation genetic testing for monogenic disorders (PGT-M): experience of two high-volume fertility clinics | 27.3 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion | 27.3 | 0 | 2 |
| Vaginal microbiota profile at the time of embryo transfer does not affect live birth rate in IVF cycles with donated oocytes | 27.3 | 0 | 2 |
| Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome | 27.3 | 0 | 2 |
| Performance of preimplantation genetic testing for aneuploidy in IVF cycles for patients with advanced maternal age, repeat implantation failure, and idiopathic recurrent miscarriage | 27.3 | 0 | 2 |
| The Impact of Traditional Medicine-Based Lifestyle and Diet on Infertility Treatment in Women Undergoing Assisted Reproduction: A Randomized Controlled Trial | 27.3 | 0 | 2 |
| Cleavage Stage versus Blastocyst Stage Embryo Transfer in Oocyte Donation Cycles | 27.3 | 0 | 2 |
| Single or double embryo transfer? Decision-making process in patients participating in an oocyte donation program | 27.3 | 0 | 2 |
| Evaluation of the effect of the elective blastocyst-stage embryo transfer and freezing strategy on the abandonment of frozen embryos under the Taiwan National Assisted Reproduction Act | 27.3 | 0 | 2 |
| Spontaneous Conception during In Vitro Fertilization prior to Embryo Transfer without the Opportunity for Preimplantation Genetic Testing | 27.3 | 0 | 2 |
| A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed Frozen Embryo Transfer (FET) Following a Freeze-all Strategy | 27.3 | 0 | 2 |
| Genetic screening of in vitro fertilization (IVF)-embryo transfer (ET) patients | 27.3 | 0 | 2 |
| [Elective single embryo transfer in assisted reproduction] | 27.3 | 0 | 2 |
| Changes in the levels of selected metabolites in the culture medium as a possible tool for the embryo selection in assisted reproduction | 27.3 | 0 | 2 |
| Repetitive oocyte donation: a committee opinion | 27.3 | 0 | 2 |
| Preimplantation genetic testing and chances of a healthy live birth amongst recipients of fresh donor oocytes in the United States | 27.3 | 0 | 2 |
| Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics | 27.3 | 0 | 2 |
| Is Preimplantation Genetic Testing Associated with Increased Risk of Abnormal Placentation After Frozen Embryo Transfer? | 27.3 | 0 | 2 |
| Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion | 27.3 | 0 | 2 |
| Ng Soon Chye | 27.3 | 0 | 2 |
| HCG trigger versus GnRH agonist trigger in PCOS patients undergoing IVF cycles: frozen embryo transfer outcomes | 27.3 | 0 | 2 |
| Early Progesterone Change Associated With Pregnancy Outcome After Fresh Embryo Transfer in Assisted Reproduction Technology Cycles With Progesterone Level of >1.5 ng/ml on Human Chorionic Gonadotropin Trigger Day | 27.3 | 0 | 2 |
| Donor oocyte recipients do not benefit from preimplantation genetic testing for aneuploidy to improve pregnancy outcomes | 27.3 | 0 | 2 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 27.3 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 27.3 | 0 | 2 |
| Day-5 fresh embryo transfer is associated with superior clinical outcomes in oocyte donation cycles compared with day-3 embryo transfer | 27.3 | 0 | 2 |
| Cardiometabolic and Thrombotic Risk Profile in Women Undergoing Oocyte Donation for Assisted Reproduction | 27.3 | 0 | 2 |
| Outcome of mock embryo transfer before the first IVF cycle: A randomized control trial | 27.3 | 0 | 2 |
| Simulation training for embryo transfer: findings from the American Society for Reproductive Medicine Embryo Transfer Certificate Course | 27.3 | 0 | 2 |
| Experiences of women undergoing infertility treatment from embryo transfer until pregnancy test and their conceptualization of their embryo | 27.3 | 0 | 2 |
| Women’s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy | 27.3 | 0 | 2 |
| Hysteroscopy With Fundus Uterus Scratching Incision VS Office Hysteroscopy Before ET With Donor Eggs | 27.3 | 0 | 2 |
| Effect of Embryo Migration in Fresh Oocyte Donation Cycles | 27.3 | 0 | 2 |
| Analysis of the Composition of the Vaginal Microbiota During IVF Treatment and Correlation With Serum Progesterone Level on the Day of Embryo Transfer | 27.3 | 0 | 2 |
| Corrigendum to: The ethics of preconception expanded carrier screening in patients seeking assisted reproduction | 27.3 | 0 | 2 |
| P–090 Cumulative live birth rates (CLBR) per embryo transfer, embryo transferred and inseminated oocyte are not affected by paternal age in infertile male donor egg cycles | 27.3 | 0 | 2 |
| Recentering Labor in the Egg Donation Bioeconomy: Egg Donors’ (Re)productive Work and Subjectification in Spain | 27.3 | 0 | 2 |
| Choice of fresh homologous or fresh donor embryo transfer is determined primarily by availability of insurance-mandated in vitro fertilization (IVF) coverage and university versus private practice. | 27.3 | 0 | 2 |
| Depression and Anxiety in Infertility: a Comparison of Patients Undergoing IVF Cycles Using Donor Eggs and Autologous Eggs | 27.3 | 0 | 2 |
| Application and Challenge of Preimplantation Genetic Testing in Reproductive Medicine | 27.3 | 0 | 2 |
| Preimplantation genetic testing (PGT) is associated with higher odds of a healthy livebirth among donor oocyte recipients in the United States: a 2013-2015 national study | 27.3 | 0 | 2 |
| Optimizing utilization of emotional support during infertility treatment | 27.3 | 0 | 2 |
| The effect of advancing paternal age on pregnancy and neonatal outcomes following a single euploid frozen embryo transfer in a donor oocyte model | 27.3 | 0 | 2 |
| Blastocyst morphology correlates with preimplantation genetic testing for aneuploidy (PGT-A) results and may further predict pregnancy potential after euploid single embryo transfer (SET) | 27.3 | 0 | 2 |
| Pregnancy rates following single euploid embryo transfer are unchanged in gestational carrier compared to non-gestational carrier in vitro fertilization cycles | 27.3 | 0 | 2 |
| Does massage therapy immediately prior to embryo transfer improve clinical pregnancy rate in IVF-PGT-A (in-vitro fertilization-preimplantation genetic testing for aneuploidy) cycles? | 27.3 | 0 | 2 |
| Changes in U.S. utilization of donor egg IVF cycles at different female ages between 2005-2016 | 27.3 | 0 | 2 |
| Dydrogesterone for prevent LH surge yields similar outcomes to ganirelix in a shared oocyte donor cycle with subsequent frozen-thawed embryo transfer: comparison of donors and recipients | 27.3 | 0 | 2 |
| Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a sart-cors study | 27.3 | 0 | 2 |
| Preimplantation genetic testing (PGT) and frozen embryo transfer (FET) synergistically decrease pre-term delivery in patients undergoing in vitro fertilization (IVF) | 27.3 | 0 | 2 |
| Impact of preimplantation genetic testing for aneuploidy (PGT-A) on gestational carrier (GC) cycles in the United States | 27.3 | 0 | 2 |
| IMPACT OF EXPANDED CARRIER SCREENING (ECS) ON UPTAKE OF PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) | 27.3 | 0 | 2 |
| 8. COMPARISON OF NATURAL CYCLES VERSUS HORMONE REPLACEMENT TREATMENT FOR 2398 FROZEN–THAWED EMBRYO TRANSFER CYCLES FOR PREIMPLANTATION GENETIC TESTING PATIENTS | 27.3 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy: a pragmatic, multicenter randomized clinical trial of single frozen euploid embryo transfer versus selection by morphology alone | 27.3 | 0 | 2 |
| Comparison of different platforms for preimplantation genetic testing in IVF cycle | 27.3 | 0 | 2 |
| A New Cost-efficient Single Nucleotide Polymorphism (SNP) Preimplantation Genetic TESTING (PGT) Assay for Beta-thalassaemia and simultaneous use with Preimplantation Genetic Screening (PGS) | 27.3 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy (PGT-A) in donor oocyte single blastocyst transfer cycles: is there benefit? | 27.3 | 0 | 2 |
| Association between the number of oocytes retrieved and cumulative live birth rate in IVF treatment: menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial outcomes | 27.3 | 0 | 2 |
| What are the benefits and harms of intrauterine administration of human chorionic gonadotropin (hCG) around the time of embryo transfer for subfertile women undergoing assisted reproduction? | 27.3 | 0 | 2 |
| Perceptions of reproductive healthcare providers regarding their involvement in offering expanded carrier screening in fertility clinics: a qualitative study | 27.3 | 0 | 2 |
| Does embryo biopsy, independent of vitrification, impact perinatal outcomes? An analysis of perinatal outcomes following preimplantation genetic testing biopsy in fresh and frozen embryo transfer cycles | 27.3 | 0 | 2 |
| Obstetric and Perinatal Outcomes of Pregnancies After Infertility Treatment Using Assisted Reproductive Technologies With Cryopreserved Embryo Transfer | 27.3 | 0 | 2 |
| Do donor oocyte recipients benefit from preimplantation genetic testing for aneuploidy(PGT-A) to improve pregnancy outcomes? | 27.3 | 0 | 2 |
| Client experience and use of expanded carrier screening results as part of the semen donor selection process | 27.3 | 0 | 2 |
| Do blastulation rates correlate with embryo ploidy? a comparison of 1,552 IVF cycles with preimplantation genetic testing stratified by age and percent blastulation | 27.3 | 0 | 2 |
| Initial serum human chorionic gonadotropin levels predict live birth outcomes following frozen embryo transfer with and without preimplantation genetic testing for aneuploidy (PGT-A) | 27.3 | 0 | 2 |
| How does freeze-all strategy compare with conventional in vitro fertilization and fresh embryo transfer during assisted reproduction? | 27.3 | 0 | 2 |
| Q135965364 | 27.3 | 0 | 2 |
| Cyprus Fertina IVF Clinic | 27.3 | 0 | 2 |
| From scarcity to sisterhood: The framing of egg donation on fertility clinic websites in the UK, Belgium and Spain | 27.3 | 0 | 2 |
| Let ‘Pregnant Women Choose the Destiny for Themselves and Their Child’. How Fertility Clinic Digital Platforms Frame Preimplantation Genetic Testing (PGT) in Spain | 27.3 | 0 | 2 |
| GYN-FIV a.s. | 27.3 | 0 | 2 |
| Systems Biology in Reproductive Medicine | 17.2 | 0 | 1 |
| Robert Edwards | 17.2 | 0 | 1 |
| embryo transfer | 17.2 | 0 | 1 |
| genetic testing | 17.2 | 0 | 1 |
| reproductive medicine | 17.2 | 0 | 1 |
| Dor Yeshorim | 17.2 | 0 | 1 |
| Creighton Model FertilityCare System | 17.2 | 0 | 1 |
| Volunteer Emotional Support Helplines | 17.2 | 0 | 1 |
| Volks | 17.2 | 0 | 1 |
| AirCraft Casualty Emotional Support Services | 17.2 | 0 | 1 |
| genetic screen | 17.2 | 0 | 1 |
| Center for Reproductive Medicine | 17.2 | 0 | 1 |
| covert incest | 17.2 | 0 | 1 |
| emotional support animal | 17.2 | 0 | 1 |
| fertility tourism | 17.2 | 0 | 1 |
| Human Fertilisation and Embryology (Deceased Fathers) Act 2003 | 17.2 | 0 | 1 |
| Medicare Part D coverage gap | 17.2 | 0 | 1 |
| Newborn Screening Saves Lives Act of 2007 | 17.2 | 0 | 1 |
| Penn State IFC/Panhellenic Dance Marathon | 17.2 | 0 | 1 |
| medical costs | 17.2 | 0 | 1 |
| reproductive surgery | 17.2 | 0 | 1 |
| semen collection | 17.2 | 0 | 1 |
| Slovenian fertility treatment referendum, 2001 | 17.2 | 0 | 1 |
| Special Program of Assisted Reproduction | 17.2 | 0 | 1 |
| Category:A-Class reproductive medicine articles | 17.2 | 0 | 1 |
| Category:B-Class reproductive medicine articles | 17.2 | 0 | 1 |
| Category:C-Class reproductive medicine articles | 17.2 | 0 | 1 |
| Category:FA-Class reproductive medicine articles | 17.2 | 0 | 1 |
| Category:FL-Class reproductive medicine articles | 17.2 | 0 | 1 |
| Category:GA-Class reproductive medicine articles | 17.2 | 0 | 1 |
| Category:High-importance reproductive medicine articles | 17.2 | 0 | 1 |
| Category:Low-importance reproductive medicine articles | 17.2 | 0 | 1 |
| Category:Mid-importance reproductive medicine articles | 17.2 | 0 | 1 |
| Category:Reproductive medicine articles by importance | 17.2 | 0 | 1 |
| Category:Reproductive medicine articles by quality | 17.2 | 0 | 1 |
| Category:Reproductive medicine task force | 17.2 | 0 | 1 |
| Category:Reproductive medicine task force articles | 17.2 | 0 | 1 |
| Category:NA-Class reproductive medicine pages | 17.2 | 0 | 1 |
| Category:NA-importance reproductive medicine pages | 17.2 | 0 | 1 |
| Category:Start-Class reproductive medicine articles | 17.2 | 0 | 1 |
| Category:Stub-Class reproductive medicine articles | 17.2 | 0 | 1 |
| Category:Top-importance reproductive medicine articles | 17.2 | 0 | 1 |
| Category:Unassessed reproductive medicine articles | 17.2 | 0 | 1 |
| Category:Unknown-importance reproductive medicine articles | 17.2 | 0 | 1 |
| Category:List-Class reproductive medicine articles | 17.2 | 0 | 1 |
| Seminars in Reproductive Medicine | 17.2 | 0 | 1 |
| Molecular Human Reproduction | 17.2 | 0 | 1 |
| Journal of Reproductive Medicine | 17.2 | 0 | 1 |
| Obstetrics, Gynaecology and Reproductive Medicine | 17.2 | 0 | 1 |
| Anna Glasier | 17.2 | 0 | 1 |
| Partner-assisted reproduction | 17.2 | 0 | 1 |
| carrier testing | 17.2 | 0 | 1 |
| Rest on the Flight into Egypt | 17.2 | 0 | 1 |
| Harbor at Honfleur | 17.2 | 0 | 1 |
| Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study | 17.2 | 0 | 1 |
| Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies | 17.2 | 0 | 1 |
| Reproductive medicine in northwest Argentina: traditional and institutional systems | 17.2 | 0 | 1 |
| Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS) | 17.2 | 0 | 1 |
| Metabolic and genetic screening of electromagnetic hypersensitive subjects as a feasible tool for diagnostics and intervention | 17.2 | 0 | 1 |
| WikiProject Reproductive medicine | 17.2 | 0 | 1 |
| Consensus on infertility treatment related to polycystic ovary syndrome | 17.2 | 0 | 1 |
| donor selection | 17.2 | 0 | 1 |
| Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome | 17.2 | 0 | 1 |
| An historical look at embryo transfer | 17.2 | 0 | 1 |
| Naprotechnology | 17.2 | 0 | 1 |
| Interactions of sperm perinuclear theca with the oocyte: implications for oocyte activation, anti-polyspermy defense, and assisted reproduction | 17.2 | 0 | 1 |
| Scientific and ethical aspects of genetic screening of workers for cancer risk: The case of the n-acetyltransferase phenotype | 17.2 | 0 | 1 |
| Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction | 17.2 | 0 | 1 |
| Temperature of embryo culture for assisted reproduction | 17.2 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 17.2 | 0 | 1 |
| Long-acting FSH versus daily FSH for women undergoing assisted reproduction | 17.2 | 0 | 1 |
| Luteal phase support for assisted reproduction cycles | 17.2 | 0 | 1 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 17.2 | 0 | 1 |
| Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction | 17.2 | 0 | 1 |
| Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction | 17.2 | 0 | 1 |
| Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease | 17.2 | 0 | 1 |
| Time-lapse systems for embryo incubation and assessment in assisted reproduction | 17.2 | 0 | 1 |
| Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction | 17.2 | 0 | 1 |
| Advanced sperm selection techniques for assisted reproduction | 17.2 | 0 | 1 |
| Vasodilators for women undergoing fertility treatment | 17.2 | 0 | 1 |
| Time-lapse systems for embryo incubation in assisted reproduction | 17.2 | 0 | 1 |
| Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI) | 17.2 | 0 | 1 |
| Fresh versus frozen embryo transfers for assisted reproduction | 17.2 | 0 | 1 |
| In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction | 17.2 | 0 | 1 |
| Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction | 17.2 | 0 | 1 |
| Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction | 17.2 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 17.2 | 0 | 1 |
| Advanced sperm selection techniques for assisted reproduction | 17.2 | 0 | 1 |
| Heparin for assisted reproduction | 17.2 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 17.2 | 0 | 1 |
| Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction | 17.2 | 0 | 1 |
| Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles | 17.2 | 0 | 1 |
| Androgens (dehydroepiandrosterone or testosterone) in women undergoing assisted reproduction | 17.2 | 0 | 1 |
| Pain relief for women undergoing oocyte retrieval for assisted reproduction | 17.2 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 17.2 | 0 | 1 |
| Vasodilators for women undergoing assisted reproduction | 17.2 | 0 | 1 |
| Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction | 17.2 | 0 | 1 |
| Long-acting FSH versus daily FSH for women undergoing assisted reproduction | 17.2 | 0 | 1 |
| Long-acting FSH versus daily FSH for women undergoing assisted reproduction | 17.2 | 0 | 1 |
| Immune therapies for women with history of failed implantation undergoing IVF treatment | 17.2 | 0 | 1 |
| Luteal phase support for assisted reproduction cycles | 17.2 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 17.2 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 17.2 | 0 | 1 |
| Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction | 17.2 | 0 | 1 |
| Heparin for assisted reproduction | 17.2 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation | 17.2 | 0 | 1 |
| Luteal phase support for assisted reproduction cycles | 17.2 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 17.2 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 17.2 | 0 | 1 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 17.2 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 17.2 | 0 | 1 |
| In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction | 17.2 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 17.2 | 0 | 1 |
| Luteal phase support in assisted reproduction cycles | 17.2 | 0 | 1 |
| Cycle regimens for frozen-thawed embryo transfer | 17.2 | 0 | 1 |
| Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI) | 17.2 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 17.2 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 17.2 | 0 | 1 |
| Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI) | 17.2 | 0 | 1 |
| Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection | 17.2 | 0 | 1 |
| Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection | 17.2 | 0 | 1 |
| In vitro maturation in sub fertile patients with polycystic ovarian syndrome undergoing assisted reproduction | 17.2 | 0 | 1 |
| Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles | 17.2 | 0 | 1 |
| Soft versus firm embryo transfer catheters for assisted reproductive technology | 17.2 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted conception | 17.2 | 0 | 1 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles | 17.2 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 17.2 | 0 | 1 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 17.2 | 0 | 1 |
| Luteal phase support in assisted reproduction cycles | 17.2 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 17.2 | 0 | 1 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 17.2 | 0 | 1 |
| In memoriam: Celso-Ramon Garcia, M.D. (1922-2004), reproductive medicine visionary | 17.2 | 0 | 1 |
| Frozen-thawed embryo transfer cycles: clinical outcomes of single and double blastocyst transfers | 17.2 | 0 | 1 |
| Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease | 17.2 | 0 | 1 |
| Carrier screening in individuals of Ashkenazi Jewish descent | 17.2 | 0 | 1 |
| Reverse genetic screening identifies five E-class PPR proteins involved in RNA editing in mitochondria of Arabidopsis thaliana | 17.2 | 0 | 1 |
| The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States | 17.2 | 0 | 1 |
| Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment | 17.2 | 0 | 1 |
| A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening | 17.2 | 0 | 1 |
| Infertility, infertility treatment, and congenital malformations: Danish national birth cohort | 17.2 | 0 | 1 |
| Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria | 17.2 | 0 | 1 |
| Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening | 17.2 | 0 | 1 |
| Beckwith-Wiedemann syndrome and assisted reproduction technology (ART) | 17.2 | 0 | 1 |
| Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a retrospective analysis | 17.2 | 0 | 1 |
| First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy | 17.2 | 0 | 1 |
| Genomic imprinting and assisted reproduction | 17.2 | 0 | 1 |
| The minisequencing method: a simple strategy for genetic screening of MEN 2 families | 17.2 | 0 | 1 |
| Monochorionic-triamniotic triplet pregnancy after intracytoplasmic sperm injection, assisted hatching, and two-embryo transfer: first reported case following IVF | 17.2 | 0 | 1 |
| Article processing charges, funding, and open access publishing at Journal of Experimental & Clinical Assisted Reproduction | 17.2 | 0 | 1 |
| A focused and efficient genetic screening strategy in the mouse: identification of mutations that disrupt cortical development | 17.2 | 0 | 1 |
| The stork and the syringe: a political history of reproductive medicine | 17.2 | 0 | 1 |
| Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility | 17.2 | 0 | 1 |
| Clarifying the role of three-dimensional transvaginal sonography in reproductive medicine: an evidenced-based appraisal | 17.2 | 0 | 1 |
| The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment | 17.2 | 0 | 1 |
| Engineering a rare-cutting restriction enzyme: genetic screening and selection of NotI variants | 17.2 | 0 | 1 |
| Category:Medicine/Reproductive medicine task force articles needing expert attention | 17.2 | 0 | 1 |
| Genetic screening and monitoring for workers | 17.2 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 17.2 | 0 | 1 |
| Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer | 17.2 | 0 | 1 |
| Synergies between assisted reproduction technologies and functional genomics | 17.2 | 0 | 1 |
| Models Predicting Success of Infertility Treatment: A Systematic Review | 17.2 | 0 | 1 |
| Maternal and fetal outcomes in oocyte donation pregnancies | 17.2 | 0 | 1 |
| Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET) | 17.2 | 0 | 1 |
| Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer: a network meta-analysis | 17.2 | 0 | 1 |
| Fertility treatment in spinal cord injury and other neurologic disease | 17.2 | 0 | 1 |
| Non-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive Medicine | 17.2 | 0 | 1 |
| Expanded carrier screening: A review of early implementation and literature | 17.2 | 0 | 1 |
| Clinical determinants of mental disorders occurring during the infertility treatment | 17.2 | 0 | 1 |
| Parthenogenesis and Human Assisted Reproduction | 17.2 | 0 | 1 |
| Update on Canine and Feline Blood Donor Screening for Blood-Borne Pathogens | 17.2 | 0 | 1 |
| Recommendation to Reduce Patients' Blood Pressure and Cholesterol Medication Costs | 17.2 | 0 | 1 |
| Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review | 17.2 | 0 | 1 |
| Bibliometric mapping and clustering analysis of Iranian papers on reproductive medicine in Scopus database (2010-2014) | 17.2 | 0 | 1 |
| Sperm selection in natural conception: what can we learn from Mother Nature to improve assisted reproduction outcomes? | 17.2 | 0 | 1 |
| Air quality in the assisted reproduction laboratory: a mini-review | 17.2 | 0 | 1 |
| Stem cells in reproductive medicine: ready for the patient? | 17.2 | 0 | 1 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 17.2 | 0 | 1 |
| New advances of preimplantation and prenatal genetic screening and noninvasive testing as a potential predictor of health status of babies | 17.2 | 0 | 1 |
| Psychological Screening/Phenotyping as Predictors for Spinal Cord Stimulation | 17.2 | 0 | 1 |
| The presence, role and clinical use of spermatozoal RNAs | 17.2 | 0 | 1 |
| Genetic screening for the risk of type 2 diabetes: worthless or valuable? | 17.2 | 0 | 1 |
| Infertility and reproductive medicine clinics of North America | 17.2 | 0 | 1 |
| Iranian journal of reproductive medicine Yazd Research & Clinical Centre for Infertility | 17.2 | 0 | 1 |
| Clinical and experimental reproductive medicine | 17.2 | 0 | 1 |
| Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis | 17.2 | 0 | 1 |
| Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs | 17.2 | 0 | 1 |
| The future role of genetic screening to detect newborns at risk of childhood-onset hearing loss | 17.2 | 0 | 1 |
| Reproduction and Breast Cancer Risk | 17.2 | 0 | 1 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 17.2 | 0 | 1 |
| Influence of anti-HBc positive organ donor in lung donor selection | 17.2 | 0 | 1 |
| Lung donor selection criteria | 17.2 | 0 | 1 |
| BRCAGenetic Screening in Middle Eastern and North African: Mutational Spectrum and FounderBRCA1Mutation (c.798_799delTT) in North African | 17.2 | 0 | 1 |
| The longer-term health outcomes for children born as a result of IVF treatment. Part II-Mental health and development outcomes | 17.2 | 0 | 1 |
| Optimal pig donor selection in islet xenotransplantation: current status and future perspectives | 17.2 | 0 | 1 |
| Conjoined human oocytes observed during assisted reproduction: description of three cases and review of the literature | 17.2 | 0 | 1 |
| Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care? | 17.2 | 0 | 1 |
| “Is It Worth Knowing?” Focus Group Participants’ Perceived Utility of Genomic Preconception Carrier Screening | 17.2 | 0 | 1 |
| A Genetic Screening Strategy Identifies Novel Regulators of the Proteostasis Network | 17.2 | 0 | 1 |
| Mary Barton | 17.2 | 0 | 1 |
| PGS-FISH in reproductive medicine and perspective directions for improvement: a systematic review | 17.2 | 0 | 1 |
| Journal of in vitro fertilization and embryo transfer : IVF | 17.2 | 0 | 1 |
| Assisted reproduction reviews | 17.2 | 0 | 1 |
| Annual progress in reproductive medicine | 17.2 | 0 | 1 |
| Journal of experimental & clinical assisted reproduction | 17.2 | 0 | 1 |
| International journal of reproductive medicine | 17.2 | 0 | 1 |
| International journal of gynecological obstetrical and reproductive medicine research | 17.2 | 0 | 1 |
| Journal of fertilization. In vitro IVF worldwide reproductive medicine genetics & stem cell biology | 17.2 | 0 | 1 |
| JBRA assisted reproduction | 17.2 | 0 | 1 |
| Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysis | 17.2 | 0 | 1 |
| Recent advances in prenatal genetic screening and testing | 17.2 | 0 | 1 |
| Abdominal ectopic pregnancy after in vitro fertilization and single embryo transfer: a case report and systematic review | 17.2 | 0 | 1 |
| Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review | 17.2 | 0 | 1 |
| Are there optimal numbers of oocytes, spermatozoa and embryos in assisted reproduction? | 17.2 | 0 | 1 |
| Should Sabbath Prohibitions Be Overridden to Provide Emotional Support to a Sick Relative? | 17.2 | 0 | 1 |
| Methods for endometrial preparation in frozen-thawed embryo transfer cycles | 17.2 | 0 | 1 |
| Vitamin D and assisted reproduction: should vitamin D be routinely screened and repleted prior to ART? A systematic review | 17.2 | 0 | 1 |
| Debating Elective Single Embryo Transfer after in vitro Fertilization: A Plea for a Context-Sensitive Approach | 17.2 | 0 | 1 |
| Granulocyte colony-stimulating factor and reproductive medicine: A review | 17.2 | 0 | 1 |
| Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer | 17.2 | 0 | 1 |
| Induced Pluripotent Stem Cell Potential in Medicine, Specifically Focused on Reproductive Medicine | 17.2 | 0 | 1 |
| First do no harm: uterine natural killer (NK) cells in assisted reproduction | 17.2 | 0 | 1 |
| Influence of sexual stimulation on sperm parameters in semen samples collected via masturbation from normozoospermic men or cryptozoospermic men participating in an assisted reproduction programme | 17.2 | 0 | 1 |
| Hysteroscopic cervical canal shaving: a new therapy for cervical stenosis before embryo transfer in patients undergoing in vitro fertilization | 17.2 | 0 | 1 |
| Heparin/aspirin therapy for implantation failure in IVF cycles | 17.2 | 0 | 1 |
| Effectivity of heparin in assisted reproduction | 17.2 | 0 | 1 |
| Recurrent implantation failure in assisted reproduction: how to counsel and manage. B. Treatment options that have not been proven to benefit the couple | 17.2 | 0 | 1 |
| Autoimmune factors in assisted reproduction | 17.2 | 0 | 1 |
| Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK | 17.2 | 0 | 1 |
| Cytoplasmic transfer in assisted reproduction | 17.2 | 0 | 1 |
| Is there a benefit of low-dose aspirin in assisted reproduction? | 17.2 | 0 | 1 |
| Adjuvant therapy enhances endometrial receptivity in patients undergoing assisted reproduction | 17.2 | 0 | 1 |
| Effects of co-administration of growth hormone(GH) and aspirin to women during in vitro fertilization and embryo transfer (IVF-ET) cycles | 17.2 | 0 | 1 |
| Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate | 17.2 | 0 | 1 |
| Birth after the reimplantation of a human embryo | 17.2 | 0 | 1 |
| Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens | 17.2 | 0 | 1 |
| Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety | 17.2 | 0 | 1 |
| Transplantation in reproductive medicine: previous experience, present knowledge and future prospects | 17.2 | 0 | 1 |
| Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure | 17.2 | 0 | 1 |
| Listing of common HLA alleles and haplotypes based on the study of 356 families residing in the Paris, France, area: implications for unrelated hematopoietic stem cell donor selection | 17.2 | 0 | 1 |
| Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program | 17.2 | 0 | 1 |
| Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment | 17.2 | 0 | 1 |
| The use of donor eggs and embryos in the management of human infertility | 17.2 | 0 | 1 |
| Genetic screening in the workplace: ethical issues | 17.2 | 0 | 1 |
| Successful treatment of cervical stenosis with hysteroscopic canalization before embryo transfer in patients undergoing IVF: a case series | 17.2 | 0 | 1 |
| Clinical significance of sperm DNA damage in assisted reproduction outcome | 17.2 | 0 | 1 |
| Oocyte donation in patients with Turner's syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy | 17.2 | 0 | 1 |
| Dynamics and ethics of comprehensive preimplantation genetic testing: a review of the challenges | 17.2 | 0 | 1 |
| Serum progestagen-associated endometrial protein (PEP) levels in conception versus nonconception cycles following in vitro fertilization-embryo transfer | 17.2 | 0 | 1 |
| Pregnancy and assisted reproduction techniques in men and women after cancer treatment | 17.2 | 0 | 1 |
| Carrier screening for spinal muscular atrophy | 17.2 | 0 | 1 |
| Raman microspectroscopy: shining a new light on reproductive medicine | 17.2 | 0 | 1 |
| Q28344605 | 17.2 | 0 | 1 |
| Births after transfer of zona-free blastocysts in oocyte donation cycles | 17.2 | 0 | 1 |
| A PTSD symptoms trajectory mediates between exposure levels and emotional support in police responders to 9/11: a growth curve analysis | 17.2 | 0 | 1 |
| Increased count, motility, and total motile sperm cells collected across three consecutive ejaculations within 24 h of oocyte retrieval: implications for management of men presenting with low numbers of motile sperm for assisted reproduction | 17.2 | 0 | 1 |
| Urinary bisphenol A concentrations and association within vitrofertilization outcomes among women from a fertility clinic | 17.2 | 0 | 1 |
| Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic | 17.2 | 0 | 1 |
| Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic | 17.2 | 0 | 1 |
| Soy Intake Modifies the Relation Between Urinary Bisphenol A Concentrations and Pregnancy Outcomes Among Women Undergoing Assisted Reproduction | 17.2 | 0 | 1 |
| Dietary folate intake and modification of the association of urinary bisphenol A concentrations with in vitro fertilization outcomes among women from a fertility clinic | 17.2 | 0 | 1 |
| Hair mercury concentrations and in vitro fertilization (IVF) outcomes among women from a fertility clinic | 17.2 | 0 | 1 |
| The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial | 17.2 | 0 | 1 |
| Dietary Folate and Reproductive Success Among Women Undergoing Assisted Reproduction | 17.2 | 0 | 1 |
| Parental contributions to early embryo development: influences of urinary phthalate and phthalate alternatives among couples undergoing IVF treatment | 17.2 | 0 | 1 |
| Paternal Urinary Concentrations of Parabens and Other Phenols in Relation to Reproductive Outcomes among Couples from a Fertility Clinic | 17.2 | 0 | 1 |
| Bergen Shopping Addiction Scale | 17.2 | 0 | 1 |
| Preimplantation genetic screening | 17.2 | 0 | 1 |
| Newborn genetic screening for hearing impairment: a preliminary study at a tertiary center | 17.2 | 0 | 1 |
| Forward genetic screening for the improved production of fermentable sugars from plant biomass | 17.2 | 0 | 1 |
| Biomarkers in reproductive medicine: the promise, and can it be fulfilled? | 17.2 | 0 | 1 |
| Ontogeny of adenosine deaminase in the mouse decidua and placenta: immunolocalization and embryo transfer studies | 17.2 | 0 | 1 |
| Effect of sperm DNA fragmentation on clinical outcome of frozen-thawed embryo transfer and on blastocyst formation | 17.2 | 0 | 1 |
| Forward genetic screening identifies a small molecule that blocks Toxoplasma gondii growth by inhibiting both host- and parasite-encoded kinases | 17.2 | 0 | 1 |
| Congenital Malformations among Babies Born Following Letrozole or Clomiphene for Infertility Treatment | 17.2 | 0 | 1 |
| Three Giants in the Cradle of Reproductive Medicine; Reproduction Theories of the Seventeenth Century as Discerned by Pregnancy Portraiture in the Oeuvre of Jan Vermeer | 17.2 | 0 | 1 |
| Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials | 17.2 | 0 | 1 |
| Roger Gosden | 17.2 | 0 | 1 |
| 'Ancient' DNA in the resting egg bank of a microcrustacean can serve as a palaeolimnological database | 17.2 | 0 | 1 |
| Approaches to prenatal cystic fibrosis carrier screening | 17.2 | 0 | 1 |
| The effect of intrauterine human chorionic gonadotropin injection before embryo transfer on the implantation and pregnancy rate in infertile patients: A randomized clinical trial | 17.2 | 0 | 1 |
| A Chemical Genetic Screening Procedure for Arabidopsis thaliana Seedlings | 17.2 | 0 | 1 |
| Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos | 17.2 | 0 | 1 |
| Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome | 17.2 | 0 | 1 |
| The effect of endometrial injury on pregnancy rate in frozen-thawed embryo transfer: A randomized control trial | 17.2 | 0 | 1 |
| Application of human haploid cell genetic screening model in identifying the genes required for resistance to environmental toxicants: Chlorpyrifos as a case study | 17.2 | 0 | 1 |
| GIFT The Hope for Future Infertility Treatment | 17.2 | 0 | 1 |
| Genetic Screening for Prey in the Gut Contents from a Giant Squid (Architeuthis sp.) | 17.2 | 0 | 1 |
| Urinary Concentrations of Phthalate Metabolites in Relation to Pregnancy Loss among Women Conceiving with Medically Assisted Reproduction | 17.2 | 0 | 1 |
| The attitudes and intention to participate in hemoglobinopathy carrier screening in The Netherlands among individuals from Turkish, Moroccan, and Surinamese descent | 17.2 | 0 | 1 |
| Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune | 17.2 | 0 | 1 |
| Blood donor screening for West Nile virus (WNV) revealed acute Usutu virus (USUV) infection, Germany, September 2016 | 17.2 | 0 | 1 |
| William F. Crowley | 17.2 | 0 | 1 |
| Hysteroscopic polypectomy prior to infertility treatment: A cost analysis and systematic review | 17.2 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. | 17.2 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation. | 17.2 | 0 | 1 |
| Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis | 17.2 | 0 | 1 |
| GnRH-agonist triggering for final oocyte maturation in GnRH-antagonist IVF cycles induces decreased LH pulse rate and amplitude in early luteal phase: a possible luteolysis mechanism | 17.2 | 0 | 1 |
| Current and future role of genetic screening in gynecologic malignancies | 17.2 | 0 | 1 |
| Howard and Georgeanna Jones Foundation for Reproductive Medicine | 17.2 | 0 | 1 |
| How teacher emotional support motivates students: The mediating roles of perceived peer relatedness, autonomy support, and competence | 17.2 | 0 | 1 |
| Men with a complete absence of normal sperm morphology exhibit high rates of success without assisted reproduction | 17.2 | 0 | 1 |
| Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome. | 17.2 | 0 | 1 |
| Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility | 17.2 | 0 | 1 |
| Institute for Reproductive Medicine | 17.2 | 0 | 1 |
| Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics | 17.2 | 0 | 1 |
| Clinical, emotional support vital to success of AIDS unit | 17.2 | 0 | 1 |
| A public philosophy of assisted reproduction for New York State | 17.2 | 0 | 1 |
| Alternative treatments in reproductive medicine. The vexing problem of 'seemingly impeccable trials...'. | 17.2 | 0 | 1 |
| Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination | 17.2 | 0 | 1 |
| Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes | 17.2 | 0 | 1 |
| Recruitment strategies in two reproductive medicine network infertility trials | 17.2 | 0 | 1 |
| Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome | 17.2 | 0 | 1 |
| Infertile couples' experience of family stress while women are hospitalized for ovarian hyperstimulation syndrome during infertility treatment | 17.2 | 0 | 1 |
| Randomized Trial of Harp Therapy During In Vitro Fertilization–Embryo Transfer | 17.2 | 0 | 1 |
| Smoking in infertile women with polycystic ovary syndrome: baseline validation of self-report and effects on phenotype. | 17.2 | 0 | 1 |
| Distributive justice and infertility treatment in Canada | 17.2 | 0 | 1 |
| Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations | 17.2 | 0 | 1 |
| The impact of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT) on short term diabetic medication costs | 17.2 | 0 | 1 |
| Sperm or oocyte donation: the dynamics of making the decision regarding the method and timing of disclosure of information to the sibling | 17.2 | 0 | 1 |
| First-trimester diagnosis and management of Cesarean scar pregnancies after in vitro fertilization-embryo transfer: a retrospective clinical analysis of 12 cases | 17.2 | 0 | 1 |
| Prevention of prematurity by single embryo transfer | 17.2 | 0 | 1 |
| Letrozole versus clomiphene for infertility in the polycystic ovary syndrome | 17.2 | 0 | 1 |
| Regulating (or not) reproductive medicine: an alternative to letting the market decide | 17.2 | 0 | 1 |
| Genetic screening for hypersusceptibles in industry | 17.2 | 0 | 1 |
| Patient Education and Emotional Support Practices in Abortion Care Facilities in the United States | 17.2 | 0 | 1 |
| Breast cancer genetic screening and critical bioethics' gaze. | 17.2 | 0 | 1 |
| Body mass index and intercourse compliance | 17.2 | 0 | 1 |
| Altering hirsutism through ovulation induction in women with polycystic ovary syndrome | 17.2 | 0 | 1 |
| The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome | 17.2 | 0 | 1 |
| A philosopher looks at assisted reproduction | 17.2 | 0 | 1 |
| Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome | 17.2 | 0 | 1 |
| Inhibin, activin, and follistatin in reproductive medicine | 17.2 | 0 | 1 |
| Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism | 17.2 | 0 | 1 |
| Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial | 17.2 | 0 | 1 |
| Predictors of pregnancy in women with polycystic ovary syndrome. | 17.2 | 0 | 1 |
| Can instructional and emotional support in the first-grade classroom make a difference for children at risk of school failure? | 17.2 | 0 | 1 |
| Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial | 17.2 | 0 | 1 |
| Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome. | 17.2 | 0 | 1 |
| Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction | 17.2 | 0 | 1 |
| Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene | 17.2 | 0 | 1 |
| Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome | 17.2 | 0 | 1 |
| Genetic screening in a university clinic: impact of primary language | 17.2 | 0 | 1 |
| Comprehensive genetic screening of KCNQ4 in a large autosomal dominant nonsyndromic hearing loss cohort: genotype-phenotype correlations and a founder mutation. | 17.2 | 0 | 1 |
| Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidates | 17.2 | 0 | 1 |
| The glycinergic system in human startle disease: a genetic screening approach | 17.2 | 0 | 1 |
| Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. | 17.2 | 0 | 1 |
| Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial | 17.2 | 0 | 1 |
| In vitro fertilization - analysis of data in Czech National Assisted Reproduction Register from years 2007-2011 | 17.2 | 0 | 1 |
| Improved pregnancy and birth rates with routine application of nonsurgical embryo transfer | 17.2 | 0 | 1 |
| The collection of data on assisted reproduction treatments in the UK: Recommendations by BFS and ACE | 17.2 | 0 | 1 |
| Obligatory versus elective single embryo transfer in in vitro fertilization. A population-based analysis of data from the U.K. Human Fertilisation and Embryology Authority | 17.2 | 0 | 1 |
| Cultivation of the notochord of a Balanoglossus species in diffusion chambers | 17.2 | 0 | 1 |
| Establishment of lipiodol as a fertility treatment – Prospective study of the complete innovative treatment data set | 17.2 | 0 | 1 |
| Medical genetics in reproductive medicine | 17.2 | 0 | 1 |
| Laser-assisted hatching in assisted reproduction. | 17.2 | 0 | 1 |
| Patient-Health Care Provider Conversations About Prenatal Genetic Screening: Recommendation or Personal Choice | 17.2 | 0 | 1 |
| It ‘did what it said on the tin’ – Participant's views of the content and process of donor conception parenthood preparation workshops | 17.2 | 0 | 1 |
| Safety issues in assisted reproduction technology. From theory to reality--just what are the data telling us about ICSI offspring health and future fertility and should we be concerned? | 17.2 | 0 | 1 |
| Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech. | 17.2 | 0 | 1 |
| The merits of blastocyst versus cleavage stage embryo transfer: a Cochrane review | 17.2 | 0 | 1 |
| Selection-subtraction approach (SSA): a universal genetic screening technique that enables negative selection | 17.2 | 0 | 1 |
| Proteomics of human spermatozoa, protamine content and assisted reproduction outcome. | 17.2 | 0 | 1 |
| High-throughput genetic screening using matrix-assisted laser desorption/ionization mass spectrometry | 17.2 | 0 | 1 |
| Data processing and exchange tools to facilitate chemical genetic screening processes | 17.2 | 0 | 1 |
| Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape | 17.2 | 0 | 1 |
| A rapid genetic screening system for identifying gene-specific suppression constructs for use in human cells | 17.2 | 0 | 1 |
| Keeping the Spirits Up: The Effect of Teachers' and Parents' Emotional Support on Children's Working Memory Performance. | 17.2 | 0 | 1 |
| Assisted hatching in assisted reproduction | 17.2 | 0 | 1 |
| Zona hardening, zona drilling and assisted hatching: new achievements in assisted reproduction | 17.2 | 0 | 1 |
| The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis | 17.2 | 0 | 1 |
| Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study | 17.2 | 0 | 1 |
| ["Screening" in special situations. Assessing predictive genetic screening for hereditary breast and colorectal cancer]. | 17.2 | 0 | 1 |
| Gaps in the evidence for fertility treatment-an analysis of the Cochrane Menstrual Disorders and Subfertility Group database | 17.2 | 0 | 1 |
| Risk of major congenital anomalies after assisted hatching: analysis of three-year data from the national assisted reproduction registry in Japan | 17.2 | 0 | 1 |
| Low health literacy associated with higher medication costs in patients with type 2 diabetes mellitus: Evidence from matched survey and health insurance data. | 17.2 | 0 | 1 |
| Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion | 17.2 | 0 | 1 |
| Risk of preterm birth after blastocyst embryo transfer: a large population study using contemporary registry data from Australia and New Zealand. | 17.2 | 0 | 1 |
| Public opinion regarding oocyte donation in Turkey: first data from a secular population among the Islamic world. | 17.2 | 0 | 1 |
| Reliability of HLA-Cw data collected in unrelated bone marrow registry and their usefulness for preliminary donor selection. | 17.2 | 0 | 1 |
| West Nile virus infections projected from blood donor screening data, United States, 2003 | 17.2 | 0 | 1 |
| Serum estradiol:oocyte ratio as a predictor of reproductive outcome: an analysis of data from >9000 IVF cycles in the Republic of Ireland. | 17.2 | 0 | 1 |
| Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011–2012 | 17.2 | 0 | 1 |
| GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology | 17.2 | 0 | 1 |
| Could induced apoptosis of human granulosa cells predict in vitro fertilization-embryo transfer outcome? A preliminary study of 25 women. | 17.2 | 0 | 1 |
| Tissue perfusion essential for spermatogenesis and outcome of testicular sperm extraction (TESE) for assisted reproduction | 17.2 | 0 | 1 |
| Update on the comparison of assisted reproduction outcomes between Europe and the USA: the 2002 data | 17.2 | 0 | 1 |
| The German Middleway as Precursor for Single Embryo Transfer. A Retrospective Data-analysis of the Düsseldorf University Hospital's Interdisciplinary Fertility Centre - UniKiD. | 17.2 | 0 | 1 |
| Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation | 17.2 | 0 | 1 |
| IVF with preimplantation genetic screening, a promising new treatment with unexpectedly negative health outcomes: the Hippocratic role of Data Monitoring Committees | 17.2 | 0 | 1 |
| Medical devices; obstetrical and gynecological devices; classification of the assisted reproduction laser system. Final rule. | 17.2 | 0 | 1 |
| The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data | 17.2 | 0 | 1 |
| Assisted reproduction: data from France | 17.2 | 0 | 1 |
| Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening. | 17.2 | 0 | 1 |
| Effect of fibroids on fertility in patients undergoing assisted reproduction. A structured literature review | 17.2 | 0 | 1 |
| Possible applications of a non-contact 1.48 microm wavelength diode laser in assisted reproduction technologies | 17.2 | 0 | 1 |
| Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles | 17.2 | 0 | 1 |
| Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April-August 2016 | 17.2 | 0 | 1 |
| Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients | 17.2 | 0 | 1 |
| Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome | 17.2 | 0 | 1 |
| Genetic screening of candidate genes for a prothrombotic interaction with type I protein C deficiency in a large kindred | 17.2 | 0 | 1 |
| Rapid assays for detection of anti-islet autoantibodies: implications for organ donor screening | 17.2 | 0 | 1 |
| Effect of a single dose of ibuprofen lysinate before embryo transfer on pregnancy rates in cows | 17.2 | 0 | 1 |
| Utility of genetic screening in hypertrophic cardiomyopathy: prevalence and significance of novel and double (homozygous and heterozygous) beta-myosin mutations. | 17.2 | 0 | 1 |
| Long QT syndrome in South Africa: the results of comprehensive genetic screening | 17.2 | 0 | 1 |
| Depot versus daily administration of GnRH agonist protocols for pituitary desensitization in assisted reproduction cycles: a Cochrane Review | 17.2 | 0 | 1 |
| Laser in assisted reproduction and genetics | 17.2 | 0 | 1 |
| Proteomics in reproductive medicine: the technology for separation and identification of proteins | 17.2 | 0 | 1 |
| A randomized double-blind controlled study of the efficacy of laser-assisted hatching on implantation and pregnancy rates of frozen-thawed embryo transfer at the cleavage stage. | 17.2 | 0 | 1 |
| Microscopical advances in assisted reproduction. | 17.2 | 0 | 1 |
| Risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes | 17.2 | 0 | 1 |
| Triazine-based tyrosinase inhibitors identified by chemical genetic screening | 17.2 | 0 | 1 |
| Australian attitudes to DNA sample banks and genetic screening | 17.2 | 0 | 1 |
| Present state of reproductive medicine in Japan - ethical issues with a focus on those seen in court cases | 17.2 | 0 | 1 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion | 17.2 | 0 | 1 |
| Applications of microarray in reproductive medicine. | 17.2 | 0 | 1 |
| A list and analysis of reproductive medicine periodicals indexed in MEDLINE in 2006 | 17.2 | 0 | 1 |
| Isolation of intracellular proteinase inhibitors derived from designed ankyrin repeat proteins by genetic screening | 17.2 | 0 | 1 |
| Laser-induced thrombosis in zebrafish larvae: a novel genetic screening method for thrombosis | 17.2 | 0 | 1 |
| Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial | 17.2 | 0 | 1 |
| An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity | 17.2 | 0 | 1 |
| Effect of passive uterine straightening during embryo transfer: a systematic review and meta-analysis | 17.2 | 0 | 1 |
| Identification of novel pigmentation modulators by chemical genetic screening | 17.2 | 0 | 1 |
| Cost-utility analysis of genetic screening in families of patients with germline MUTYH mutations | 17.2 | 0 | 1 |
| Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage. | 17.2 | 0 | 1 |
| Effect of laser zona pellucida opening on clinical outcome of assisted reproduction technology in patients with advanced female age, recurrent implantation failure, or frozen-thawed embryos | 17.2 | 0 | 1 |
| Emotional support, education and self-rated health in 22 European countries | 17.2 | 0 | 1 |
| A comparison of manual therapy and active rehabilitation in the treatment of non specific low back pain with particular reference to a patient's Linton & Hallden psychological screening score: a pilot study | 17.2 | 0 | 1 |
| Chemical genetic screening identifies tricyclic compounds that decrease cellular melanin content | 17.2 | 0 | 1 |
| Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis | 17.2 | 0 | 1 |
| A yeast-based genetic screening to identify human proteins that increase homologous recombination | 17.2 | 0 | 1 |
| Effect of the size of zona pellucida opening by laser assisted hatching on clinical outcome of frozen cleaved embryos that were cultured to blastocyst after thawing in women with multiple implantation failures of embryo transfer: a retrospective stu | 17.2 | 0 | 1 |
| Impact of assisted hatching on fresh and frozen-thawed embryo transfer cycles: a prospective, randomized study | 17.2 | 0 | 1 |
| Pretreatments before the induction of ovulation in assisted reproduction technologies: evidence-based medicine in 2007. | 17.2 | 0 | 1 |
| Outpatient hysteroscopy and subsequent IVF cycle outcome: a systematic review and meta-analysis | 17.2 | 0 | 1 |
| Genetic screening in haemolytic uraemic syndrome | 17.2 | 0 | 1 |
| Flow cytometric phenotyping of platelet HPA-1a antigen: donor screening for a case of neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies. | 17.2 | 0 | 1 |
| Chromosomal abnormalities in miscarriages after different assisted reproduction procedures. | 17.2 | 0 | 1 |
| Functional genetic screening reveals the role of mitochondrial cytochrome b as a mediator of FAS-induced apoptosis | 17.2 | 0 | 1 |
| A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario | 17.2 | 0 | 1 |
| Indications and options for endometrial ablation | 17.2 | 0 | 1 |
| Alkylation of sperm DNA is associated with male factor infertility and a reduction in the proportion of oocytes fertilised during assisted reproduction. | 17.2 | 0 | 1 |
| Controversies in clinical embryology: embryo selection towards single embryo transfer - 16 July 2008, University of Manchester | 17.2 | 0 | 1 |
| Effect of stem cell activation, culture media of manipulated embryos, and site of embryo transfer in the production of F0 embryonic stem cell mice. | 17.2 | 0 | 1 |
| Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine | 17.2 | 0 | 1 |
| Multifetal gestations with assisted reproductive technique before the single-embryo transfer legislation: obstetric, neonatal outcomes and congenital anomalies | 17.2 | 0 | 1 |
| Fatal alloimmune thrombocytopenia due to anti-HLA alloimmunization in a twin pregnancy: A very infrequent complication of assisted reproduction | 17.2 | 0 | 1 |
| Sex, parthenogenesis and genetic structure of rotifers: microsatellite analysis of contemporary and resting egg bank populations. | 17.2 | 0 | 1 |
| Analysis of 127 stem cell donations of the regional Bone Marrow Donor Bank Europdonor Nijmegen, The Netherlands | 17.2 | 0 | 1 |
| Optimizing donor selection in a cord blood bank | 17.2 | 0 | 1 |
| Bone marrow transplantation for chronic myelogenous leukemia in blastic phase using a phenotypically identical unrelated volunteer donor. Nagoya Bone Marrow Transplantation Group (NBMTG), Tokai Marrow Donor Bank (TMDB) | 17.2 | 0 | 1 |
| Donor screening for hepatitis B virus infection in a cell and tissue bank | 17.2 | 0 | 1 |
| Mode and size of HPA-typed platelet apheresis donor bank in Chinese Han population | 17.2 | 0 | 1 |
| A homozygous mutant embryonic stem cell bank applicable for phenotype-driven genetic screening | 17.2 | 0 | 1 |
| Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types | 17.2 | 0 | 1 |
| Role of lymphocytotoxicity and staph-protein A assays in platelet donor selection. | 17.2 | 0 | 1 |
| Leukemia: recent progress in diagnosis and treatment. Topics: IV. Recent topics; 3. The advances of bone marrow donor bank and cord blood bank | 17.2 | 0 | 1 |
| Private egg bank to protect fertility against aging | 17.2 | 0 | 1 |
| Advances in microsurgery and assisted reproduction for management of male infertility | 17.2 | 0 | 1 |
| Study of the effects of the implementation of a human milk donor bank in preterm newborns in Aragon | 17.2 | 0 | 1 |
| Population genetic dynamics of an invasion reconstructed from the sediment egg bank | 17.2 | 0 | 1 |
| Analyses of Factors Affecting Endothelial Cell Density in an Eye Bank Corneal Donor Database | 17.2 | 0 | 1 |
| Histocompatibility (HL-A-)antigens of 1000 blood donors: a contribution to setting-up a platelet-, leukocyte- and bone-marrow-donor bank (author's transl) | 17.2 | 0 | 1 |
| Artificial insemination and use of a sperm bank at the fertility clinic of the C.H.U.L. (Centre hospitalier de l'université Larval) | 17.2 | 0 | 1 |
| Utilization of bone marrow donor bank | 17.2 | 0 | 1 |
| Genotyping analysis of HLA-class II and III genes in unrelated bone marrow transplantation among Japanese. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank. | 17.2 | 0 | 1 |
| Bone marrow transplantation from donors other than HLA matched siblings for hematological malignancies. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank | 17.2 | 0 | 1 |
| Analysis of 55 transplantations from unrelated volunteer donors facilitated by Tokai Marrow Donor Bank. | 17.2 | 0 | 1 |
| Low versus atmospheric oxygen tension for embryo culture in assisted reproduction: a systematic review and meta-analysis | 17.2 | 0 | 1 |
| Blood group genotyping: from patient to high-throughput donor screening | 17.2 | 0 | 1 |
| Incorporating natural variation into IVF clinic league tables: The Expected Rank | 17.2 | 0 | 1 |
| Genetic screening of 104 patients with congenitally malformed hearts revealed a fresh mutation of GATA4 in those with atrial septal defects | 17.2 | 0 | 1 |
| Donor availability for platelet transfusion support of alloimmunized thrombocytopenic patients | 17.2 | 0 | 1 |
| Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients | 17.2 | 0 | 1 |
| Chemical genetic screening in the zebrafish embryo | 17.2 | 0 | 1 |
| Preimplantation genetic testing | 17.2 | 0 | 1 |
| Significance of reproductive medicine in regard to judicial and ethical concerns in Germany | 17.2 | 0 | 1 |
| Embryo recovery rate and recipients' pregnancy rate after nonsurgical embryo transfer in donkeys | 17.2 | 0 | 1 |
| Effect of laser zona thinning on vitrified-warmed embryo transfer at the cleavage stage: a prospective, randomized study | 17.2 | 0 | 1 |
| Embryo transfer in rabbits | 17.2 | 0 | 1 |
| Thalassemia carrier screening and prenatal diagnosis among the British Columbia (Canada) population of Chinese descent | 17.2 | 0 | 1 |
| Does assisted reproduction make an impact on the identity and self-image of infertile couples? | 17.2 | 0 | 1 |
| Does assisted reproduction make an impact on the identity and self-esteem of infertile women during the transition to parenthood? | 17.2 | 0 | 1 |
| Assisted reproduction for the treatment of azoospermia | 17.2 | 0 | 1 |
| Ovarian markers of implantation potential in assisted reproduction | 17.2 | 0 | 1 |
| The application of co-culture in assisted reproduction: 10 years of experience with human embryos | 17.2 | 0 | 1 |
| Hyperactivated motility of human spermatozoa: a review of physiological function and application in assisted reproduction | 17.2 | 0 | 1 |
| Preparation of endometrium for egg donation | 17.2 | 0 | 1 |
| More than "bandaids": emotional support and education during the downsizing process | 17.2 | 0 | 1 |
| Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome | 17.2 | 0 | 1 |
| Dairy intake and semen quality among men attending a fertility clinic | 17.2 | 0 | 1 |
| Vitrification of human embryos subjected to blastomere biopsy for pre-implantation genetic screening produces higher survival and pregnancy rates than slow freezing | 17.2 | 0 | 1 |
| Increasing and decreasing factors of hope in infertile women with failure in infertility treatment: A phenomenology study | 17.2 | 0 | 1 |
| Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial | 17.2 | 0 | 1 |
| Abuse in childhood and risk of uterine leiomyoma: the role of emotional support in biologic resilience | 17.2 | 0 | 1 |
| Risk management in transfusion medicine. The AIDS era underscores the need for a unified, comprehensive risk management program for all aspects of transfusion--from donor selection to post-transfusion outcomes. | 17.2 | 0 | 1 |
| Institutional review boards (IRBs) and reproductive medicine: guidelines for compliance | 17.2 | 0 | 1 |
| Stevens-Johnson Syndrome following Failure of Genetic Screening prior to Carbamazepine Prescription. | 17.2 | 0 | 1 |
| The status of assisted reproductive technology in Korea in 2012 | 17.2 | 0 | 1 |
| The State of Reproductive Medicine in Germany | 17.2 | 0 | 1 |
| Should patients with recent onset rheumatoid arthritis be offered genetic screening? | 17.2 | 0 | 1 |
| Should patients with recent onset of rheumatoid arthritis be offered genetic screening? | 17.2 | 0 | 1 |
| The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis | 17.2 | 0 | 1 |
| Assessment of endometrial and ovarian characteristics using three dimensional power Doppler ultrasound to predict response in frozen embryo transfer cycles | 17.2 | 0 | 1 |
| Elective single embryo transfer following in vitro fertilization | 17.2 | 0 | 1 |
| Personal care product use and urinary phthalate metabolite and paraben concentrations during pregnancy among women from a fertility clinic | 17.2 | 0 | 1 |
| Retrospective clinical analysis of two artificial shrinkage methods applied prior to blastocyst vitrification on the outcome of frozen embryo transfer | 17.2 | 0 | 1 |
| Knowledge and perceptions of haemoglobinopathy carrier screening among general practitioners in Cardiff | 17.2 | 0 | 1 |
| The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing | 17.2 | 0 | 1 |
| Effects of genetic screening on perceptions of health: a pilot study | 17.2 | 0 | 1 |
| Principles and practicalities of carrier screening: attitudes of recent parents | 17.2 | 0 | 1 |
| Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic. | 17.2 | 0 | 1 |
| A new approach to prenatal cystic fibrosis carrier screening | 17.2 | 0 | 1 |
| 'Inside-out', back-to-front: a model for clinical population genetic screening | 17.2 | 0 | 1 |
| Pre-implantation genetic screening using fluorescence in situ hybridization in couples of Indian ethnicity: Is there a scope? | 17.2 | 0 | 1 |
| Can letrozole plus HMG protocol improve pregnancy outcomes in frozen-thawed embryo transfer? An RCT | 17.2 | 0 | 1 |
| The Internet, intranets and reproductive medicine | 17.2 | 0 | 1 |
| What factors are important for successful embryo transfer after in-vitro fertilization? | 17.2 | 0 | 1 |
| Identification of mosaic and segmental aneuploidies by next-generation sequencing in preimplantation genetic screening can improve clinical outcomes compared to array-comparative genomic hybridization | 17.2 | 0 | 1 |
| Molecular pathology and cancer genetic screening. | 17.2 | 0 | 1 |